| Literature DB >> 34181358 |
Martha Ervina1, Hadi Poerwono2, Retno Widyowati2, Hideaki Otsuka3, Katsuyoshi Matsunami4, Sukardiman Sukardiman2.
Abstract
OBJECTIVE: Nature has provided us with many pharmaceutical resources so far. Breast cancer shows an increasing trend in the world for the last decade and becomes one of five leading causes of death. Among the plants, Melia azedarach L. has been used widely in traditional medicine for many ailments including breast cancer. Following our previous findings that the ethyl acetate fraction was the most active cytotoxic fraction against T47D cells, we aimed to isolate the cytotoxic compounds and further elucidate their apoptotic mechanisms.Entities:
Keywords: Apoptosis; Cytotoxicity; Melia azedarach; T47D; breast cancer
Mesh:
Substances:
Year: 2021 PMID: 34181358 PMCID: PMC8418864 DOI: 10.31557/APJCP.2021.22.6.1967
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
The MTT Cytotoxic Results of the Subfraction and Isolates
| Sub fractions (ME) | IC50 (µg/mL)* |
|---|---|
| 11 | 95.29±3.26b |
| 12 | 119.17±5.74b |
| 13 | 209.07±5.26c |
| 14 | >500f |
| 15 | 294.62±3.02d |
| 16 | 343.40±11.57de |
| 17 | 379.69±5.84e |
| 18 | 342.95±4.60de |
| 19 | 395.27±19.79e |
| Compound 1 | 172.91±3.75bc |
| Compound 2 | 62.15±1.37b |
| Compound 3 | >500f |
| Doxorubicin | 3.08±0.20a |
* different superscript letter means Anova statistically significant (p < 0.05) between the means in the same column
13C and 1H NMR Data of Compounds 1 and 2 (CDOD3, 400 MHz, J in Hz).
| No | signal (δ, ppm) | |||
|---|---|---|---|---|
| 13C | 1H | |||
| 1 | 2 | 1 | 2 | |
| 1 | 37.49 | 36.88 | 2,19 (s, H) | 1.88 (s, H) |
| 2 | 25,80 | 26.00 | 2.06 (t, | 1,97 (m) |
| 3 | 73.81 | 73.95 | 3.42 (m, 1H) | 3.42 (dt, |
| 4 | 78.52 | 78.64 | 4.06 (s, 1H) | 4.04 (d, |
| 5 | 144.78 | 145.00 | - | - |
| 6 | 127.99 | 128.19 | 5.63 (dd, 1H) | 5.61 (dd, |
| 7 | 32.9 | 32.35 | 2.13 (dd, | |
| 8 | 37,39 | 32.92 | 1.85 (d, 3H) | 2.13 (m, |
| 9 | 51.88 | 51.92 | 1.45 (m) | 0.96 (s,1H); 3.28 (t, |
| 10 | 38,87 | 38.57 | - | - |
| 11 | 21.54 | 21.68 | 2.39 (d, | 1.06 (d, |
| 12 | 32.02 | 37.68 | 1.56 (m); 1.13 (t, 2H) | 1.85 (t); 1.57 (m), |
| 13 | 38.41 | 40.52 | 1.69 (d) | - |
| 14 | 44.41 | 51.55 | - | 2.10 (d, |
| 15 | 51.52 | 44.39 | 2.02 (s, 1H), 2.19 (d, | 2.14 (d, |
| 16 | 208.56 | 210.94 | - | - |
| 17 | 149.45 | 149.77 | - | - |
| 18 | 16.1 | 20.01 | 1.06 (s, 3H) | 0.92 (s, 3H) |
| 19 | 21.54 | 21.48 | 1.24 (s, 3H) | 1.22 (s, H) |
| 20 | 130.9 | 131.99 | 6.47 (q, | 5.78 (q, |
| 21 | 13.51 | 14.33 | 1.87 ((d, | 2.02 (d, |
Figure 1Structure of Compounds 1 (A) 17-ethylene-3,4-dihydroxy-14-methyl-18-norandrostene-14-methyl-16-one and 2 (B) 17-ethylene-3,4-dihydroxy-5-pregnene-16-one
Figure 2.Flowcytometer with PI-annexin Staining Results of the ME127A, 127C and Doxorubicin for A = control cells, B = doxorubicin, compounds C = 1, D= 2, 1= 24 and 2 = 48 hours, phases cell Q1= necrosis, Q2 = late apoptosis, Q3 = viable cells, Q4 = early apoptosis
Figure 3Flowcytometer Histogram Results of the Control (N), Apoptosis (A) and Necrosis (N) Cells for 24 and 48 hours of the Compounds 1, 2 and Doxorubicin
Figure 4The Histogram of Microscopic Count of the p53, BAX and bcl-2 Immunocytochemistry with Antibody Reagents and Hematoxylins Staining Results of the Compounds 1, 2 and Doxorubicin